# Comparative Study of Loxoprofen Sodium Transdermal Patch and Loxonin® Tablets for the Treatment of Acute Trauma

> **NCT02616068** · PHASE3 · COMPLETED · sponsor: **Daiichi Sankyo Brasil Farmacêutica LTDA** · enrollment: 242 (actual)

## Conditions studied

- Trauma
- Pain

## Interventions

- **DRUG:** Transdermal Patch
- **DRUG:** Loxoprofen sodium
- **DRUG:** Placebo (for loxoprofen sodium)
- **DRUG:** Placebo (for transdermal patch)

## Key facts

- **NCT ID:** NCT02616068
- **Lead sponsor:** Daiichi Sankyo Brasil Farmacêutica LTDA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-10
- **Primary completion:** 2016-12
- **Final completion:** 2016-12
- **Target enrollment:** 242 (ACTUAL)
- **Last updated:** 2017-02-14

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02616068

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02616068, "Comparative Study of Loxoprofen Sodium Transdermal Patch and Loxonin® Tablets for the Treatment of Acute Trauma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02616068. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*